These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Binding of sulfinpyrazone and its metabolites in human serum and in solutions of human serum albumin. Jakobsen P, Pedersen AK, Andreasen F. Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):243-9. PubMed ID: 7136730 [Abstract] [Full Text] [Related]
13. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin. Veronich K, White G, Kapoor A. J Pharm Sci; 1979 Dec 11; 68(12):1515-8. PubMed ID: 529041 [Abstract] [Full Text] [Related]
14. Interaction between warfarin and sulphamethoxazole. Tilstone WJ, Gray JM, Nimmo-Smith RH, Lawson DH. Postgrad Med J; 1977 Jul 11; 53(621):388-90. PubMed ID: 882479 [Abstract] [Full Text] [Related]
17. The interaction of enflurane, halothane and the halothane metabolite trifluoroacetic acid with the binding of acidic drugs to human serum albumin. An in vitro study. Dale O. Biochem Pharmacol; 1986 Feb 15; 35(4):557-61. PubMed ID: 3947389 [Abstract] [Full Text] [Related]
18. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Fehske KJ, Schläfer U, Wollert U, Müller WE. Mol Pharmacol; 1982 Mar 15; 21(2):387-93. PubMed ID: 6808349 [Abstract] [Full Text] [Related]